HDAC2 and colorectal carcinoma: Moreover, histone acetylation modifications hold prognostic value; expressions of SIRT1, HDAC1, and HDAC2, along with levels of H3K56Ac and H4K16Ac, serve as potential prognostic markers for CRC.